{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T15:57:39Z","timestamp":1680191859125},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/rlu.0b013e31829b9d6b","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T14:00:48Z","timestamp":1372514448000},"page":"739-740","source":"Crossref","is-referenced-by-count":6,"title":["Metastatic Prostate Cancer Proven by 18F-FCH PET\/CT Staging Scan in Patient With Normal PSA but High PSA Doubling Time"],"prefix":"10.1097","volume":"38","author":[{"given":"Marina","family":"Hodoli\u010d","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Margherita","family":"Maffione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jure","family":"Fettich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borut","family":"Gubina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Cimitan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ejrad.2010.07.023","article-title":"Choline PETCT for prostate cancer: main clinical applications.","volume":"80","author":"Fuccio","year":"2011","journal-title":"Eur J Radiol"},{"key":"R2-15-20210204","first-page":"55","article-title":"Is there a role for 11C-choline PETCT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase 1.5 ngml Eur J Nucl Med Mol Imaging.","volume":"38","author":"Castellucci","year":"2011","journal-title":""},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0022-5347(01)66713-2","article-title":"The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies.","volume":"154","author":"Oefelein","year":"1995","journal-title":"J Urol"},{"key":"R4-15-20210204","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/1097-0142(19951215)76:12<2530::AID-CNCR2820761219>3.0.CO;2-F","article-title":"Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level.","volume":"76","author":"Leibman","year":"1995","journal-title":"Cancer"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/RLU.0b013e318266cc38","article-title":"Role of 18F-choline PETCT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution.","volume":"38","author":"Marzola","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/RLU.0b013e31823363b0","article-title":"Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PETCT in prostate cancer patients with biochemical failure after radical prostatectomy.","volume":"37","author":"Giovacchini","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R7-15-20210204","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-012-0908-z","article-title":"Impact of total PSA, PSA doubling time and PSA velocity on detection rates of (11)C-choline positron emission tomography in recurrent prostate cancer.","volume":"31","author":"Rybalov","year":"2013","journal-title":"World J Urol"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1007\/s00259-011-2030-7","article-title":"PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PETCT detection rate in patients with rising PSA after radical prostatectomy.","volume":"39","author":"Schillaci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e31829b9d6b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:31:17Z","timestamp":1621884677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201309000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31829b9d6b","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}